3 Crazy Facts About Canopy Growth's Largest Acquisition in Marijuana History
Canopy's $3.4 billion purchase of Acreage Holdings is unlike anything Wall Street or investors have ever seen.
Harvest Health CEO Steve White Talks Cannabis Consolidation, Says Canopy-Acreage Tie-Up 'Fantastic'
Harvest Health & Recreation, Inc. (OTC: HRVSF ) CEO Steve White joined Yahoo's Jeff Lagerquist onstage Thursday at the Benzinga Cannabis Capital Conference to discuss consolidation in the marijuana industry. ...
Marijuana Stocks Take the Long-Term View. But Expect ‘Teething’ Problems.
Investor interest in marijuana stocks led Jefferies to hold its first cannabis conference, featuring 30 companies and 260 investors. Here are a few things that marijuana companies are thinking about for...
Canopy Growth: U.S. Future Might Not Happen
After dozens of acquisitions in the last few years, Canopy Growth ( CGC ) finally made a big move into the U.S. market. The proposed deal has a one big catch that could leave the Canadian cannabis...
High Expectations For A Budding Industry (Video)
The cannabis sector has seen some recent action after somewhat of a drought. 2017 was a breakout year for many new entrants into the medicinal marijuana realm, and many acted like crypto currencies did...
Canopy Growth Makes A Fascinating Bet On U.S. Cannabis
In the cannabis industry, innovation is key to growth, and a big part of innovation is acquiring firms that complement the parent company in question. In its latest move, the management team at Canopy...
Hot pot deal: Canopy Growth buys Acreage Holdings for $3.4 billion
Marijuana M&A heats up, as Canopy buys Acreage. Bruce Linton, Canopy CEO, and Kevin Murphy, Acrage CEO, discuss with CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Brian Kelly, Steve Grasso...
Welcome To America: Canopy Growth Purchases Acreage Holdings
Summary Canopy Growth (CGC) has announced a deal that gives the company the right to purchase Acreage Holdings ( ACRGF ) when legally permissible. Companies on a major stock exchange can't operate...
How to Know When to Buy Marijuana Stocks
A company that jumps to a major stock exchange is the "rocket ship" event of marijuana stocks. It can send shares soaring to a whole new level -- into the stratosphere.This is what my research...
5 Must-See Stock Charts for Monday: CGC, PINS, NVTA, UNP, BX
It's the same action that we've had for much of this week. Stocks press lower near the open only to recover by lunch and push higher in the afternoon. The gains aren't remarkable, but the bulls'...
Our vision is to be the number one cannabis company in the world. From product and process innovation to market execution and everything in between, we are driven by a passion for leadership, a commitment to drive the industry forward, and above all else, providing medical and recreational cannabis consumers the best possible experience.
Our StoryIn April 2014, Canopy Growth became the first cannabis company in North America to be publicly traded. We followed that with being the first to complete a “bought deal”, to diversify our platform to include both greenhouse and indoor growing, to acquire a major competitor and to be listed on the Toronto Stock Exchange. Continuing those firsts, we remain the only cannabis company to be a member of a major global stock market index, in this case the S&P/TSX Composite index.
Away from the markets, Tweed, a Canopy Growth subsidiary, was the first to introduce the now standard concept of Compassionate Pricing to make medical cannabis affordable for patients, and we remain proud to continue supporting a patient’s right to grow at home by selling the widest variety of seeds in the legal Canadian sector. Our commitment to education has and always will be unwavering, as one of the first Canadian cannabis companies to offer Mainpro-M1 accredited continuing medical education programs to Canadian physicians, and to launch in-person assistance through our Tweed Main Street locations. Tweed was also the first Canadian producer to be approved to export dried cannabis to Germany, and our wholly-owned German subsidiary continues to offer an ever-increasing variety of products for sale through German pharmacies. Canopy Growth was the first to strike a strategic relationship with a Fortune 500 beverage alcohol supplier to bring exciting new products to market, and to enter into ground-breaking supply agreements to sell adult-use cannabis to provincial governments across the country. Most recently, in May 2018, it was the first cannabis-producing company to be listed on the New York Stock Exchange.
From our cutting edge research at Canopy Health Innovations, to our hemp operations and financing services through Canopy Rivers Corporation, we are proud of our accomplishments, and are always looking for the next first.
In April 2014, Canopy Growth became the first cannabis company in North America to be publicly traded. We followed that with being the first to complete a “bought deal”, to diversify our platform to include both greenhouse and indoor growing, to acquire a major competitor and to be listed on the Toronto Stock Exchange. Continuing those firsts, we remain the only cannabis company to be a member of a major global stock market index, in this case the S&P/TSX Composite index.
Here’s to Future Growth.
Canopy Growth Corporation’s ISS Governance QualityScore as of January 28, 2019 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 6; Compensation: 10.